We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$3.6B
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.96% |
| 3 | Technology | 16.37% |
| 4 | Consumer Discretionary | 9.33% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $724M | 1.49% |
5,295,451
+32,704
| +0.6% | +$4.95M |
|
2
Microsoft
MSFT
$2.86T
| $638M | 1.31% |
2,485,076
+30,195
| +1% | +$8.2M |
|
3
Amazon
AMZN
$2.5T
| $565M | 1.16% |
5,318,307
+983,327
| +23% | +$123M |
|
4
Merck
MRK
$324B
| $529M | 1.09% |
5,801,745
-983,823
| -14% | -$87.2M |
|
5
UnitedHealth
UNH
$382B
| $519M | 1.07% |
1,009,871
-334,311
| -25% | -$168M |
|
6
Johnson & Johnson
JNJ
$634B
| $514M | 1.06% |
2,893,320
+930,025
| +47% | +$166M |
|
7
Boston Scientific
BSX
$66.1B
| $391M | 0.8% |
10,479,137
+938,755
| +10% | +$38.2M |
|
8
Thermo Fisher Scientific
TMO
$210B
| $390M | 0.8% |
718,514
+398,226
| +124% | +$219M |
|
|
9
Eli Lilly
LLY
$1.06T
| $367M | 0.76% |
+1,133,393
| New | +$340M |
|
10
Coca-Cola
KO
$353B
| $366M | 0.75% |
5,814,967
+2,943,567
| +103% | +$187M |
|
11
Broadcom
AVGO
$1.81T
| $346M | 0.71% |
7,131,790
-1,734,010
| -20% | -$97.3M |
|
|
12
Cigna
CI
$76.4B
| $340M | 0.7% |
1,289,848
+1,141,865
| +772% | +$294M |
|
13
Pfizer
PFE
$140B
| $325M | 0.67% |
6,203,088
+3,836,099
| +162% | +$195M |
|
|
14
Bank of America
BAC
$434B
| $318M | 0.65% |
10,213,335
+8,374,126
| +455% | +$302M |
|
15
Humana
HUM
$47B
| $309M | 0.63% |
659,378
+110,704
| +20% | +$49.3M |
|
16
Tesla
TSLA
$1.22T
| $301M | 0.62% |
1,342,848
+342,543
| +34% | +$93.5M |
|
17
Wells Fargo
WFC
$261B
| $297M | 0.61% |
7,583,259
-4,904,659
| -39% | -$215M |
|
18
CALL
Invesco QQQ Trust
QQQ
$455B
| $289M | 0.59% |
1,030,400
+938,100
| +1,016% | +$291M |
|
|
BHVN
19
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $281M | 0.58% |
1,928,624
-472,660
| -20% | -$60.4M |
|
20
Airbnb
ABNB
$83.9B
| $281M | 0.58% |
3,152,626
+431,790
| +16% | +$56.2M |
|
|
21
Union Pacific
UNP
$183B
| $280M | 0.58% |
1,315,137
+1,127,124
| +599% | +$256M |
|
22
Charter Communications
CHTR
$15.2B
| $276M | 0.57% |
589,588
+480,441
| +440% | +$234M |
|
|
23
TSMC
TSM
$2.1T
| $268M | 0.55% |
3,283,059
+2,970,917
| +952% | +$275M |
|
24
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $262M | 0.54% |
695,800
+675,600
| +3,345% | +$277M |
|
25
CSX Corp
CSX
$98.6B
| $251M | 0.52% |
8,643,657
+5,143,741
| +147% | +$168M |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.